Overall rank by patents
#1,087
Across all tracked assignees
USPTO PatentsView assignee record - 392 granted patents across 25 technology areas, active 2016–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: H01L (SEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10).
The verdict
Stats holds 392 US patents across 25 technology areas, rank #1,087 of 50,000 tracked assignees.
Stats Chippac Pte. Ltd. has been granted 392 US utility patents between 2016 and 2025, placing Stats Chippac Pte. Ltd. at rank #1,087 across all assignees tracked by PlainPatent. This portfolio spans 25 distinct Cooperative Patent Classification (CPC) subclasses, averaging 21.1 claims per patent with primary concentration in H01L (SEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10). As a Foreign Corporation, Stats Chippac Pte. Ltd. is one of the more focused assignees in the PatentsView dataset. By volume, Stats sits between Roche Molecular Systems, Inc. (395 patents, rank #1,083) and Ademco Inc. (390 patents, rank #1,091) - the closest US assignees by grant volume. The composite Innovation Score of 57.7/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 149 grants, compared with 243 in the 2015–2019 window, a -39% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Stats Chippac Pte. Ltd.'s 21.1 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while a multi-domain presence across 25 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Stats Chippac Pte. Ltd. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Roche Molecular Systems, Inc.
395 patents
Mueller International, LLC
393 patents
CommScope Connectivity Belgium BVBA
392 patents
FUJITSU COMPONENT LIMITED
392 patents
STATS ChipPAC Pte. Ltd.
392 patents
OXFORD UNIVERSITY INNOVATION LIMITED
391 patents
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
391 patents
WEST CORPORATION
391 patents
Ademco Inc.
390 patents
What this shows Stats holds 392 patents at rank #1,087, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #1,087 in granted patent volume.
Other assignees with the most granted patents in Stats's primary technology class.
Stats's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
58 Top 5% higher than 95% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 74 | 18.9% |
| 2017 | 91 | 23.2% |
| 2018 | 40 | 10.2% |
| 2019 | 38 | 9.7% |
| 2020 | 27 | 6.9% |
| 2021 | 11 | 2.8% |
| 2022 | 18 | 4.6% |
| 2023 | 31 | 7.9% |
| 2024 | 28 | 7.1% |
| 2025 | 34 | 8.7% |
Top 15 of 25 technology areas
Overall rank by patents
#1,087
Across all tracked assignees
57.7 out of 100
How to use this portfolio
Stats's 392 grants land it in the top 5% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.